Johns Hopkins POC-IT: Point of Care Information Technology [Home]
HIV Guide
 Zambia HIV National Guidelines
 


Introduction  

HIV Counseling and Testing  

Sexually Transmitted Infections (STIs)  

General Principles of Antiretroviral Therapy for Chronic HIV Infection in Adults and Adolescents  

When to Start ARV Therapy for Chronic HIV Infection in Adults and Adolescents  

Initial Regimen for ARV Therapy  

Adherence  

Baseline evaluation and Monitoring  

Calculations: Ideal Body Weight, Body Mass Index and Creatinine Clearance  

ARV Therapy for Individuals with Tuberculosis Co-Infection  

Adverse Effects and Toxicity  

Immune Reconstitution Inflammatory Syndrome (IRIS)  

Changing or Stopping ART  

Treatment Failure  

Stopping ARV Therapy  

Post Exposure Prophylaxis  

Cotrimoxazole Prophylaxis  

WHO Staging in Adults and Adolescents  

Nutrition Care and Support  

Palliative Care in HIV and AIDS  

 Guide Editors
 Editor In Chief
    Joel E. Gallant, MD, MPH

Pharmacology Editor
    Paul Pham, PharmD, BCPS

Zambia Guideline Team
   Peter Mwaba MMed PhD FRCP
   Alywn Mwinga MMed
   Isaac Zulu MMed MPH
   Velepie Mtonga MMed
   Albert Mwango MBChB
   Jabbin Mulwanda MMed FCS
 

 

 

Drugs>Antimicrobial Agents>
HIV Guide Home PageEmail this module to a friend

Diethyl-carbamazine

Paul A. Pham, Pharm.D. and John G. Bartlett, M.D.
06-26-2009

Zambia Specific Information

  • Available formulation in Zambia: Tablet: 50 mg; 100 mg (dihydrogen citrate).
  • First line agent for treatment of patients with lymphatic filariasis and loiasis.
  • Use with close monitoring in the treatment of onchocerciasis because diethyl-carbamazine inflammatory reaction may cause encephalopathy or permanent ocular complications. Consider corticosteroid pre-treatment.

REFERENCES

Zambia Information Author: Paul A. Pham, Pharm. D.

INDICATIONS

FDA

  • Not FDA approved, but available from the CDC (404-639-3670)
NON-FDA APPROVED USES

  • Lymphatic filaria
  • Loa loa
  • Visceral larva migrans

FORMS

brand 
name
 
generic 
Mfg 
brand 
forms
 
cost* 
Hetrazan Diethyl-carbamazine Available from the CDC 404-639-3670)oral
tab
50 mg
n/c

*Prices represent cost per unit specified and are representative of "Average Wholesale Price" (AWP). AWP Prices were obtained and gathered by Lakshmi Vasist Pharm D using the Red Book, manufacturer's information, and the McKesson database.

^Dosage is indicated in mg unless otherwise noted.

USUAL ADULT DOSING

  • Lymphatic filaria: 6 mg/kg/day PO in 3 divided doses x 14d. Diethylcarbamazine dose escalation recommended to reduce inflammatory reactions: day 1 - 50 mg, day 2 - 50 mg q8h, day 3 - 100 mg q8h, day 4 through 14 - 6 mg/kg in 3 divided doses.
  • Retreatment for microfilaremia often necessary q 6-12 mos as demonstrated by repeat blood smear or antigen testing.
  • Loiasis: 5-10 mg/kg/day PO divided into 3 doses x 2-4 wks. May require repeated treatment. If high parasitemia, consider consultation with tropical medicine expert (encephalitis risks).
  • With heavy microfilaremia, start with lower doses of diethyl-carbamazine along with corticosteroid pretreatment.

RENAL DOSING

DOSING FOR GLOMERULAR FILTRATION OF 50-80

Usual regimen.

DOSING FOR GLOMERULAR FILTRATION OF 10-50

Consider dose reduction.

DOSING FOR GLOMERULAR FILTRATION OF <10 ML/MIN

Consider dose reduction.

DOSING IN HEMODIALYSIS

No data.

DOSING IN PERITONEAL DIALYSIS

No data.

DOSING IN HEMOFILTRATION

No data.

ADVERSE DRUG REACTIONS

COMMON

  • Severe allergic or febrile reactions to dying worms in patients with microfilaria in blood or skin
  • Local reactions include lymphadenitis and transient lymphedema
  • GI intolerance (dose related)
OCCASIONAL

  • Malaise
  • Encephalopathy (with high microfilaremia)
RARE

  • Angioedema
  • Acute psychosis

DRUG INTERACTIONS

Urinary alkalinizers (sodium lactate, sodium bicarbonate): toxicity of diethyl-carbamazine may be increased due to decreased renal clearance in alkaline urine.

SPECTRUM

Wuchereria bancrofti, Brugia malayi, Brugia timori

PHARMACOLOGY

Pharmacology

COMMENTS

Must contact CDC (404-639-3670) to obtain DEC in US. Ivermectin is drug of choice for onchocerciasis because DEC inflammatory reaction may cause encephalopathy or permanent ocular complications. DEC continues to be a mainstay for Rx of pts with lymphatic filariasis and loiasis.

REFERENCES


 
Diagnosis
 


Complications of Therapy


Malignancies


Miscellaneous


Opportunistic Infections


Organ System

Drugs
 


Antimicrobial Agents


Antiretrovirals


Miscellaneous

Guidelines
 


Zambia HIV National Guidelines

Management
 


Antiretroviral Therapy


Laboratory Testing


Miscellaneous

Pathogens
 


Bacteria


Fungi


Parasites


Viruses

View All Modules
 
Index
 
 
Contacts    Help    Copyright    Acknowledgments    Abbreviations